COMPASS THERAPEUTICS, INC. (CMPX) Free cash flow 2019–2025
COMPASS THERAPEUTICS, INC. (CMPX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.2MFY2025 · since FY2019: -$32.2M → -$49.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.2M | -9.5% |
| FY2024 | -$44.9M | -10.5% |
| FY2023 | -$40.6M | -18.4% |
| FY2022 | -$34.3M | -61.7% |
| FY2021 | -$21.2M | +21.1% |
| FY2020 | -$26.9M | +16.4% |
| FY2019 | -$32.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice